Cited by 28Psychosomatic Disorders and Their TreatmentsMental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Comorbid painful physical symptoms and anxiety: Prevalence, work loss and help-seeking

Open access
Demyttenaere, Koen, Bonnewyn, Anke, Bruffaerts, Ronny, De Graaf, Ron, Haro, Josep Maria, Alonso, Jordi·2008·Journal of Affective Disorders

Abstract

Background There is evidence that painful physical symptoms (PPS) are increased in patients with anxiety disorder (AD). This survey reports the 12-month prevalence and sociodemographic characteristics of PPS in subjects with and without AD, taking into account somatic comorbidity. In addition, the impact of PPS on work loss days (WLDs) and help-seeking was examined.Methods In a cross-sectional, population-based study, a representative random sample of non-institutionalised adults from Belgium, France, Germany, Italy, The Netherlands and Spain (N=21,425) was interviewed using the World Mental Health Composite Diagnostic Interview (CIDI 3.0 of the WHO). 8296 respondents provided data on the occurrence of PPS, from which 5489 respondents reported the number of work loss days.Results PPS were reported by 28% of respondents without AD and by 45% in those with AD. Female gender, higher age and lower educational level were predictive of PPS. No additive effect of AD and PPS was found on the WLD score, neither did the presence or not of a comorbid somatic disorder change the findings. Finally, respondents with both AD and PPS had numerically higher rates of help-seeking for emotional reasons (20.8% vs. 15.0% for respondents with AD but not PPS) and delayed their help-seeking for a numerically shorter period of time (289 vs. 413 days, respectively).Limitations The most important limitation of this study was its reliance on self-reported data about somatic disorders.Conclusion Approximately 45% of persons with anxiety disorder also reported the presence of PPS. No additive effect of AD and PPS was found on the WLD score, and the presence of PPS in AD does not delay help-seeking for emotional problems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2007.12.231

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Demyttenaere, K., Bonnewyn, A., Bruffaerts, R., De Graaf, R., Haro, J. M., & Alonso, J.
Affiliations
  • Universitair Ziekenhuis Leuven (BE)
  • Institut Municipal d'Assistència Sanitària (ES)
Corresponding author
Demyttenaere, Koen
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2008-08
Volume
109
Issue
3
Pages
264-272
ISSN
0165-0327 (ISSN-L)
OpenAlex
W2101267386
Cited by
28
References
39
Citations by year
2025: 1 · 2024: 1 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 2
FWCI
2.11
Type
journal article
Language
en
Open access
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Lirias (submittedVersion, other-oa)
Funders
  • John D. and Catherine T. MacArthur Foundation
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • European Commission (QLG5–1999-01042)
  • Regione Piemonte (00/0028)
  • National Institutes of Health (5r13mh066849-04, 5r01mh069864-04)
  • Pfizer Foundation (R01‐MH069864)
  • Pan American Health Organization
  • National Institute of Mental Health (1R13 MH066849, R01‐MH069864)
  • National Institute on Drug Abuse (R01DA016558)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
anxiety disorders, somatic comorbidity, prevalence, work loss, help-seeking, help-seeking delay, sociodemographic predictors, gender differences, educational attainment
MeSH terms
Adolescent, Anxiety Disorders, Employment, Female, Humans, Male, Pain, Pain Measurement, Patient Acceptance of Health Care, Predictive Value of Tests, Prospective Studies, Psychophysiologic Disorders, Comorbidity, Prevalence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review